A detailed history of Bank Of New Hampshire transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of New Hampshire holds 16,810 shares of ABBV stock, worth $2.95 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
16,810
Previous 17,112 1.76%
Holding current value
$2.95 Million
Previous $2.94 Million 13.08%
% of portfolio
0.83%
Previous 0.77%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $49,479 - $60,197
-302 Reduced 1.76%
16,810 $3.32 Million
Q2 2024

Jul 01, 2024

SELL
$154.79 - $180.76 $255,093 - $297,892
-1,648 Reduced 8.78%
17,112 $2.94 Million
Q1 2024

Apr 10, 2024

SELL
$159.82 - $182.1 $71,439 - $81,398
-447 Reduced 2.33%
18,760 $3.42 Million
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $992,233 - $1.12 Million
-7,211 Reduced 27.3%
19,207 $2.98 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $20,305 - $23,506
-152 Reduced 0.57%
26,418 $3.94 Million
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $8,480 - $10,553
64 Added 0.24%
26,570 $3.58 Million
Q1 2023

Apr 04, 2023

SELL
$144.61 - $166.54 $88,212 - $101,589
-610 Reduced 2.25%
26,506 $4.22 Million
Q4 2022

Jan 10, 2023

SELL
$138.31 - $165.87 $249,234 - $298,897
-1,802 Reduced 6.23%
27,116 $4.38 Million
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $29,660 - $34,018
-221 Reduced 0.76%
28,918 $3.88 Million
Q2 2022

Jul 08, 2022

SELL
$137.62 - $174.96 $191,429 - $243,369
-1,391 Reduced 4.56%
29,139 $4.46 Million
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $16,233 - $20,141
123 Added 0.4%
30,530 $4.95 Million
Q4 2021

Jan 12, 2022

SELL
$107.43 - $135.93 $542,199 - $686,038
-5,047 Reduced 14.24%
30,407 $4.12 Million
Q2 2021

Jul 06, 2021

BUY
$105.21 - $117.21 $3.73 Million - $4.16 Million
35,454 New
35,454 $3.99 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.